Adetphos



Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 17.8%
Rheumatoid Arthritis 12.1%
Meniere's Disease 9.6%
Product Used For Unknown Indication 9.6%
Hypertension 8.3%
Conjunctivitis Allergic 5.1%
Sciatica 5.1%
Sudden Hearing Loss 5.1%
Tinnitus 5.1%
Osteoporosis 3.2%
Dizziness 2.5%
Gastritis Prophylaxis 2.5%
Insomnia 2.5%
Keratoconjunctivitis Sicca 2.5%
Hypercholesterolaemia 1.9%
Skeleton Dysplasia 1.9%
Conjunctivitis 1.3%
Diabetes Mellitus 1.3%
Glaucoma 1.3%
Idiopathic Pulmonary Fibrosis 1.3%
Basal Cell Carcinoma 20.8%
Liver Disorder 12.5%
Polycythaemia 12.5%
Pyrexia 12.5%
Eczema 8.3%
Memory Impairment 8.3%
Ageusia 4.2%
Drug Exposure During Pregnancy 4.2%
Eye Pain 4.2%
Hepatic Function Abnormal 4.2%
Pain 4.2%
White Blood Cell Count Decreased 4.2%
Concomitant
Product Used For Unknown Indication 15.6%
Hypertension 12.8%
Drug Use For Unknown Indication 10.7%
Dizziness 10.3%
Depression 4.3%
Prophylaxis 4.1%
Constipation 4.0%
Insomnia 4.0%
Pain 4.0%
Hepatitis C 3.8%
Asthenopia 3.5%
Gastric Ulcer 3.4%
Gastritis 3.3%
Diabetes Mellitus 3.1%
Pancreatic Neuroendocrine Tumour 2.6%
Rheumatoid Arthritis 2.5%
Cerebral Infarction 2.1%
Arteriosclerosis Obliterans 2.0%
Psoriasis 2.0%
Atrial Fibrillation 1.9%
Vomiting 15.9%
Renal Failure Acute 12.5%
Rhabdomyolysis 6.8%
Cerebral Infarction 5.7%
Pneumonia Aspiration 5.7%
Hyperammonaemia 4.5%
Interstitial Lung Disease 4.5%
Renal Impairment 4.5%
Stomatitis 4.5%
Tremor 4.5%
White Blood Cell Count Decreased 4.5%
Blood Potassium Decreased 3.4%
Hallucination, Visual 3.4%
Optic Neuritis 3.4%
Therapeutic Agent Toxicity 3.4%
Urine Output Decreased 3.4%
Altered State Of Consciousness 2.3%
Atrial Fibrillation 2.3%
Dehydration 2.3%
Drug Eruption 2.3%